| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/01/2010 | US20100168021 Urocortin proteins and uses thereof |
| 07/01/2010 | US20100168020 Stabilized receptor polypeptides and uses thereof |
| 07/01/2010 | US20100168019 Peptide conjugated anti-cancer prodrugs |
| 07/01/2010 | US20100168018 Factor viii formulations |
| 07/01/2010 | US20100168017 Functional serum protein product for use in infant food and therapeutic compositions and methods for the preparation thereof |
| 07/01/2010 | US20100168016 Diagnosis and treatment of diseases caused by misfolded proteins |
| 07/01/2010 | US20100168015 Peptides with capacity for binding with interleukine 10 (il-10) |
| 07/01/2010 | US20100168014 Screening method |
| 07/01/2010 | US20100168013 Neuromedin and FN-38 Peptides for Treating Psychiatric Diseases |
| 07/01/2010 | US20100168012 Human cancer therapy using engineered matrix metalloproteinase-activated anthrax lethal toxin that targets tumor vasculatuture |
| 07/01/2010 | US20100168011 Pharmaceutical Formulations and Methods for Making the Same |
| 07/01/2010 | US20100168010 Compositions and methods of modulating cell growth and motility |
| 07/01/2010 | US20100168009 PHa1B TOXIN, cDNA of Pha1B TOXIN GENE, PHARMACEUTICAL COMPOSITION CONTAINING PHa1B TOXIN, PROCESS AND PRODUCT |
| 07/01/2010 | US20100168008 Method of use of epiregulin protein and nucleic acid encoding the same in inflammatory conditions |
| 07/01/2010 | US20100168007 Systems and Methods for Applying Cross-Linked Mechanical Barriers |
| 07/01/2010 | US20100168006 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins |
| 07/01/2010 | US20100168005 Pyridin-3-yl derivatives as immunomodulating agents |
| 07/01/2010 | US20100168004 Methods and compositions for the synergistic activation of latent hiv |
| 07/01/2010 | US20100168003 Agent for Treating Polyglutamine Aggregation-Caused Disease or Suppressing Onset Thereof |
| 07/01/2010 | US20100168002 Therapeutic peptides |
| 07/01/2010 | US20100168001 Method for Preventing and/or Treating Articles or Media Contaminated With Bacteria of the Legionelle Genus |
| 07/01/2010 | US20100168000 Octanoate-Reduced Human Albumin |
| 07/01/2010 | US20100167999 Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps |
| 07/01/2010 | US20100167998 Growth-stimulating polypeptides for use in fish and crustaceans |
| 07/01/2010 | US20100167997 Method for stimulation collagen synthesis and/or kgf expression |
| 07/01/2010 | US20100167996 3-Ether and 3-Thioether Substituted Cyclosporin Derivatives For the Treatment and Prevention of Hepatitis C Infection |
| 07/01/2010 | US20100167995 Peptoid compounds |
| 07/01/2010 | US20100167994 Targeting of ews-fli1 as anti-tumor therapy |
| 07/01/2010 | US20100167993 Compounds for Enhancing p21 Expression and Methods of Use Thereof |
| 07/01/2010 | US20100167992 Phenyl Ester Side Chains to Increase Polymer Resorptivity |
| 07/01/2010 | US20100167991 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative |
| 07/01/2010 | US20100167990 Pharmaceutical Formulations Comprising an Insulin Derivative |
| 07/01/2010 | US20100167989 Isopropoxyphenylmethyl inhibitors of sglt2 |
| 07/01/2010 | US20100167988 Ethoxyphenylmethyl inhibitors of sglt2 |
| 07/01/2010 | US20100167987 Methods and pharmaceutical compositions for healing wounds |
| 07/01/2010 | US20100167986 Cholesteryl Ester Transfer Protein Inhibitors |
| 07/01/2010 | US20100167985 Oral insulin composition and methods of making and using thereof |
| 07/01/2010 | US20100167984 Complex between human insulin and an amphiphilic polymer and use of this complex in the preparation of a fast-acting human insulin formulation |
| 07/01/2010 | US20100167983 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis |
| 07/01/2010 | US20100167982 Barrier integrity in hiv patients |
| 07/01/2010 | US20100167981 Encapsidation of Heterologous Entities into Virus-Like Particles |
| 07/01/2010 | US20100167980 Prolyl Endopeptidase Inhibitors For Reducing or Preventing Neutrophilic Inflammation |
| 07/01/2010 | US20100167979 Rheumatoid arthritis-preventive agent for oral intake |
| 07/01/2010 | US20100167393 Modified human thymic stromal lymphopoietin |
| 07/01/2010 | US20100167392 Factor viii compositions and methods |
| 07/01/2010 | US20100167391 Growth factor homolog zvegf3 |
| 07/01/2010 | US20100167333 Heavy Metal Binding Compounds and Their Method of Use |
| 07/01/2010 | US20100167321 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same |
| 07/01/2010 | US20100166874 Technology for Preparation of Macromolecular Microspheres |
| 07/01/2010 | US20100166872 Novel improved compositions for cancer therapy |
| 07/01/2010 | US20100166867 Novel administration form of osteogenic protein complexes |
| 07/01/2010 | US20100166862 Local Complement Inhibition for Treatment of Complement-Mediated Disorders |
| 07/01/2010 | US20100166859 Novel nutraceutical compositions and use thereof |
| 07/01/2010 | US20100166855 Oral insulin composition and methods of making and using thereof |
| 07/01/2010 | US20100166849 Glutathione based delivery system |
| 07/01/2010 | US20100166847 Method for coating fine particles with lipid membrane |
| 07/01/2010 | US20100166846 Management of myoclonus with oral liposomal reduced glutathione |
| 07/01/2010 | US20100166843 Pharmaceutical composition comprising a campothecin derivative |
| 07/01/2010 | US20100166835 Compositions and uses thereof for the treatment of wounds |
| 07/01/2010 | US20100166834 Preparations based on fibrinogen and sulfated polysaccharides |
| 07/01/2010 | US20100166827 Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration |
| 07/01/2010 | US20100166824 Extracellular matrix compositions |
| 07/01/2010 | US20100166811 Gras composition for intranasal delivery of parathyroid hormone |
| 07/01/2010 | US20100166808 Method of Facilitating Intracellular Uptake or Transcellular Transport of Cargo Using Nanocarriers Containing Optimal Surface Densities of Integrin-Specific Ligands |
| 07/01/2010 | US20100166805 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 07/01/2010 | US20100166789 Proteins for use in diagnosing and treating infection and disease |
| 07/01/2010 | US20100166788 Immunogens from uropathogenic escherichia coli |
| 07/01/2010 | US20100166787 Vaccines and methods for using the same |
| 07/01/2010 | US20100166786 A mycobacterium tuberculosis fusion protein and uses thereof |
| 07/01/2010 | US20100166785 lipopeptide or lipoprotein that is not only highly immunogenic itself but also can enhance the immunogenicity of other antigens; vaccine |
| 07/01/2010 | US20100166782 Clip inhibitors and methods of modulating immune function |
| 07/01/2010 | US20100166781 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/01/2010 | US20100166777 Hematopoietic cells that express mosc-1 |
| 07/01/2010 | US20100166771 detecting NTHi bacteria in a biological sample using a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 599; vaccines and methods of treating and preventing NTHi related disorders such as NTHi infection of the middle ear and/or the nasopharynx |
| 07/01/2010 | US20100166770 Antagonists of bacterial sequences |
| 07/01/2010 | US20100166765 Benzoquinazoline derivatives |
| 07/01/2010 | US20100166761 Compositions and methods for the treatment of immune related diseases |
| 07/01/2010 | US20100166759 Metallothionein-Derived Peptide Fragments |
| 07/01/2010 | US20100166756 Method for treating an autoimmune disease using a soluble ctla4 molecule and a dmard or nsaid |
| 07/01/2010 | US20100166753 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/2010 | US20100166748 C5 Antigens and Uses Thereof |
| 07/01/2010 | US20100166747 Methods and compositions for treating tumor diseases |
| 07/01/2010 | US20100166738 Compositions and methods for wt1 specific immunotherapy |
| 07/01/2010 | US20100166737 P38Alpha as a Therapeutic Target in Bladder Carcinoma |
| 07/01/2010 | US20100166736 Immunostimulatory oligonucleotide multimers |
| 07/01/2010 | US20100166735 Methods and compositions for reduction of side effects of therapeutic treatments |
| 07/01/2010 | US20100166734 Oral delivery of polypeptides |
| 07/01/2010 | US20100166731 Methods and Compositions for Treating Cancer |
| 07/01/2010 | US20100166730 Liquid, Aqueous Pharmaceutical Composition of Factor VII Polypeptides |
| 07/01/2010 | US20100166729 Modified factor VII polypeptides and uses thereof |
| 07/01/2010 | US20100166728 Novel Highly Functional Enzyme Having Modified Substrate-Specificity |
| 07/01/2010 | US20100166727 S-Adenosylmethionine And Methylthioadensosine In Chemoprevention And Treatment Of Colon Polyps And Cancer |
| 07/01/2010 | US20100166726 Compositions for improving cellular uptake of a chemotherapeutic agent in a cell exhibiting mucin deregulation |
| 07/01/2010 | US20100166725 Human Cystathionine beta-Synthase Variants and Methods of Production Thereof |
| 07/01/2010 | US20100166724 Uses of thioredoxin |
| 07/01/2010 | US20100166723 Genes encoding nematode toxins |
| 07/01/2010 | US20100166717 Method of treating ischemic disorders |
| 07/01/2010 | US20100166715 T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery |
| 07/01/2010 | US20100166708 Antimicrobial and anti-inflammatory therapies and compositions |
| 07/01/2010 | US20100166706 Hcv ns-3 serine protease inhibitors |